Drug Profile
AVM-SC-001
Latest Information Update: 22 Sep 2023
Price :
$50
*
At a glance
- Originator AVM Biotechnology
- Class Small molecules
- Mechanism of Action Stem cell modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Stem cell mobilisation
Most Recent Events
- 22 Sep 2023 Discontinued - Preclinical for Stem cell mobilisation in USA (unspecified route) (AVM Biotechnology website, September 2023)
- 28 Jun 2018 No recent reports of development identified for preclinical development in Stem-cell-mobilisation in USA